Waddell & Reed Financial’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,930,671
| Closed | -$34M | – | 548 |
|
|
2017
Q3 | $34M | Sell |
1,930,671
-4,050,214
| -68% | -$71.3M | 0.08% | 277 |
|
|
2017
Q2 | $199M | Sell |
5,980,885
-2,099,000
| -26% | -$69.7M | 0.44% | 62 |
|
|
2017
Q1 | $259M | Sell |
8,079,885
-2,550,568
| -24% | -$81.8M | 0.55% | 49 |
|
|
2016
Q4 | $385M | Sell |
10,630,453
-6,639,455
| -38% | -$241M | 0.84% | 23 |
|
|
2016
Q3 | $795M | Sell |
17,269,908
-2,088,560
| -11% | -$96.1M | 1.64% | 4 |
|
|
2016
Q2 | $972M | Buy |
19,358,468
+896,033
| +5% | +$45M | 2.05% | 2 |
|
|
2016
Q1 | $988M | Buy |
18,462,435
+310,657
| +2% | +$16.6M | 1.85% | 3 |
|
|
2015
Q4 | $1.19B | Buy |
18,151,778
+2,304,912
| +15% | +$151M | 1.93% | 5 |
|
|
2015
Q3 | $895M | Sell |
15,846,866
-1,468,823
| -8% | -$82.9M | 1.47% | 10 |
|
|
2015
Q2 | $1.02B | Buy |
17,315,689
+74,107
| +0.4% | +$4.38M | 1.46% | 7 |
|
|
2015
Q1 | $1.07B | Buy |
17,241,582
+1,363,498
| +9% | +$84.9M | 1.49% | 10 |
|
|
2014
Q4 | $913M | Buy |
15,878,084
+1,203,796
| +8% | +$69.2M | 1.27% | 12 |
|
|
2014
Q3 | $789M | Buy |
14,674,288
+7,104,317
| +94% | +$382M | 1.09% | 19 |
|
|
2014
Q2 | $397M | Buy |
7,569,971
+1,528,869
| +25% | +$80.1M | 0.58% | 58 |
|
|
2014
Q1 | $319M | Sell |
6,041,102
-109,968
| -2% | -$5.81M | 0.48% | 65 |
|
|
2013
Q4 | $247M | Buy |
6,151,070
+1,531,330
| +33% | +$61.4M | 0.4% | 75 |
|
|
2013
Q3 | $175M | Sell |
4,619,740
-8,800
| -0.2% | -$332K | 0.33% | 84 |
|
|
2013
Q2 | $181M | Buy |
+4,628,540
| New | +$181M | 0.38% | 72 |
|